Insufficient scRNA-seq data for expression of PARS2 at single-cell level.
Insufficient scRNA-seq data for expression of PARS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 267.39 | 179 / 180 | 100% | 26.53 | 430 / 430 |
breast | 100% | 178.62 | 458 / 459 | 99% | 12.83 | 1112 / 1118 |
intestine | 100% | 283.63 | 966 / 966 | 99% | 14.35 | 522 / 527 |
skin | 100% | 297.36 | 1807 / 1809 | 99% | 13.20 | 468 / 472 |
brain | 99% | 168.70 | 2613 / 2642 | 100% | 11.41 | 704 / 705 |
esophagus | 100% | 248.65 | 1441 / 1445 | 99% | 9.64 | 181 / 183 |
uterus | 100% | 280.70 | 170 / 170 | 98% | 11.56 | 452 / 459 |
prostate | 100% | 259.91 | 245 / 245 | 98% | 10.48 | 494 / 502 |
stomach | 99% | 213.99 | 354 / 359 | 99% | 13.29 | 284 / 286 |
bladder | 100% | 238.05 | 21 / 21 | 98% | 11.24 | 493 / 504 |
thymus | 99% | 201.81 | 647 / 653 | 97% | 9.13 | 588 / 605 |
pancreas | 98% | 142.55 | 321 / 328 | 97% | 7.59 | 173 / 178 |
kidney | 100% | 262.09 | 89 / 89 | 95% | 11.08 | 855 / 901 |
liver | 100% | 197.63 | 225 / 226 | 95% | 7.55 | 386 / 406 |
lung | 83% | 120.05 | 481 / 578 | 99% | 10.04 | 1147 / 1155 |
adrenal gland | 98% | 314.09 | 254 / 258 | 76% | 5.28 | 174 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.41 | 29 / 29 |
spleen | 100% | 188.27 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.30 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 11.50 | 79 / 80 |
muscle | 99% | 210.89 | 791 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 141.26 | 1183 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 145.77 | 1302 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 164.56 | 823 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 56% | 144.57 | 516 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006433 | Biological process | prolyl-tRNA aminoacylation |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0004827 | Molecular function | proline-tRNA ligase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | PARS2 |
Protein name | Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) (Prolyl-tRNA synthetase 2, mitochondrial) |
Synonyms | |
Description | FUNCTION: Mitochondrial aminoacyl-tRNA synthetase that catalyzes the specific attachment of the proline amino acid (aa) to the homologous transfer RNA (tRNA), further participating in protein synthesis. The reaction occurs in a two steps: proline is first activated by ATP to form Pro-AMP and then transferred to the acceptor end of tRNA(Pro). . |
Accessions | ENST00000371279.4 Q7L3T8 |